Schnell O et al. Updates on cardiovascular outcome trials in diabetes. Cardiovasc Diabetol (2017) 16:128 (dostępny pełen tekst)
The present review summarizes the results of the DEVOTE, CANVAS, EXSCEL and ACE trials that tested cardiovascular safety of Insulin degludec, canagliflozin, once-weekly exenatide and acarbose and were published in 2017. We provide context on these results by comparing them with earlier trials of glucose-lowering drugs and give an outlook on what to expect in coming years.